Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life.

Journal: Southern African journal of HIV medicine

Publication Year: 

Authors & Co-authors:  Laughton Barbara B Naidoo Shalena S Dobbels Els F M T EFMT Boivin Michael J MJ van Rensburg Anita Janse AJ Glashoff Richard H RH van Zyl Gert U GU Kruger Mariana M Cotton Mark F MF

Impact of Plasma IP-10/CXCL10 and RANTES/CCL5 Levels on Neurocognitive Function in HIV Treatment-Naive Patients.

Journal: AIDS research and human retroviruses

Publication Year: 2021

Authors & Co-authors:  Ruhanya Vurayai V Jacobs Graeme B GB Naidoo Shalena S Paul Robert H RH Joska John A JA Seedat Soraya S Nyandoro George G Engelbrecht Susan S Glashoff Richard H RH

Plasma Cytokine Levels As Predictors of Global and Domain-Specific Human Immunodeficiency Virus-Associated Neurocognitive Impairment in Treatment-Naive Individuals.

Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

Publication Year: 2022

Authors & Co-authors:  Ruhanya Vurayai V Jacobs Graeme B GB Paul Robert R Joska John J Seedat Soraya S Nyandoro George G Engelbrecht Susan S Glashoff Richard H RH

Plasma Cytokine Biomarker Cutoff Values for HIV-Associated Neurocognitive Impairment in Adults.

Journal: Viral immunology

Publication Year: 2022

Authors & Co-authors:  Ruhanya Vurayai V Jacobs Graeme B GB Paul Robert H RH Joska John A JA Seedat Soraya S Nyandoro George G Engelbrecht Susan S Glashoff Richard H RH

HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment.

Journal: Journal of neurovirology

Publication Year: 2022

Authors & Co-authors:  Ruhanya Vurayai V Jacobs Graeme Brendon GB Paul Robert H RH Joska John A JA Seedat Soraya S Nyandoro George G Glashoff Richard H RH Engelbrecht Susan S